|Bid||11.50 x 2200|
|Ask||12.55 x 1400|
|Day's range||11.56 - 12.23|
|52-week range||10.99 - 39.49|
|Beta (5Y monthly)||1.07|
|PE ratio (TTM)||N/A|
|Earnings date||01 Nov 2021 - 05 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||42.45|
Short bets have risen against consumer discretionary stocks as stimulus efforts have faded, a new S&P Global Market Intelligence report found.
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long...